CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology
- PMID: 29473500
- DOI: 10.2174/1566523218666180221110627
CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology
Abstract
Genome editing mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and its associated proteins (Cas) has recently been considered to be used as efficient, rapid and site-specific tool in the modification of endogenous genes in biomedically important cell types and whole organisms. It has become a predictable and precise method of choice for genome engineering by specifying a 20-nt targeting sequence within its guide RNA. Firstly, this review aims to describe the biology of CRISPR system. Next, the applications of CRISPR-Cas9 in various ways, such as efficient generation of a wide variety of biomedically important cellular models as well as those of animals, modifying epigenomes, conducting genome-wide screens, gene therapy, labelling specific genomic loci in living cells, metabolic engineering of yeast and bacteria and endogenous gene expression regulation by an altered version of this system were reviewed.
Keywords: Applications; Biology; Biomedicine; Biotechnology; CRISPR; Cas9; Genome engineering..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
CRISPR/Cas9 Immune System as a Tool for Genome Engineering.Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):233-240. doi: 10.1007/s00005-016-0427-5. Epub 2016 Oct 3. Arch Immunol Ther Exp (Warsz). 2017. PMID: 27699445 Free PMC article. Review.
-
CRISPR/Cas9 System and its Research Progress in Gene Therapy.Anticancer Agents Med Chem. 2019;19(16):1912-1919. doi: 10.2174/1871520619666191014103711. Anticancer Agents Med Chem. 2019. PMID: 31633477 Review.
-
Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.Gene. 2020 Aug 30;753:144813. doi: 10.1016/j.gene.2020.144813. Epub 2020 May 26. Gene. 2020. PMID: 32470504 Review.
-
CRISPR/Cas9 Technology in Translational Biomedicine.Cell Physiol Biochem. 2020 Apr 17;54(3):354-370. doi: 10.33594/000000224. Cell Physiol Biochem. 2020. PMID: 32298553 Review.
-
Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape.J Ind Microbiol Biotechnol. 2018 Jul;45(7):467-480. doi: 10.1007/s10295-017-2000-6. Epub 2018 Jan 24. J Ind Microbiol Biotechnol. 2018. PMID: 29362972 Review.
Cited by
-
Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review.Front Pharmacol. 2018 Jun 12;9:630. doi: 10.3389/fphar.2018.00630. eCollection 2018. Front Pharmacol. 2018. PMID: 29946262 Free PMC article. Review.
-
DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins.Life Sci Alliance. 2022 Mar 14;5(6):e202101321. doi: 10.26508/lsa.202101321. Print 2022 Jun. Life Sci Alliance. 2022. PMID: 35288457 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials